Roivant Sciences (ROIV) Current Leases (2021 - 2026)

Roivant Sciences (ROIV) has 6 years of Current Leases data on file, last reported at $11.1 million in Q1 2026.

• Quarterly Current Leases rose 13.26% year-over-year to $11.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.1 million (up 13.26% YoY) and the FY2026 annual result came in at $11.1 million, up 13.26% from the prior year.
• Current Leases advanced to $11.1 million in Q1 2026, from $10.4 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $11.9 million in Q4 2022 to a low of $9.0 million in Q1 2024.
• A 5-year average of $10.5 million and a median of $10.5 million in 2023 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2024 — Current Leases declined 23.32% — and 2026, when it gained 13.26%.
• Tracing ROIV's Current Leases over 5 years: stood at $11.9 million in 2022, then retreated by 11.68% to $10.5 million in 2023, then declined by 6.13% to $9.8 million in 2024, then rose by 6.11% to $10.4 million in 2025, then climbed by 6.81% to $11.1 million in 2026.
• The last three Current Leases figures came in at $11.1 million (Q1 2026), $10.4 million (Q4 2025), and $9.0 million (Q3 2025), per Business Quant data.